Network Pharmacology-Based Systematic Analysis and Molecular Mechanisms of Banxia Xiexin Decoction for Chronic Atrophic Gastritis

被引:0
|
作者
Wu, Xin Rui [1 ]
Xia, G. H. [2 ]
Zhao, L. [2 ]
机构
[1] Southwest Med Univ, Coll Integrated Chinese & Western Med, Luzhou 646000, Longmatan, Peoples R China
[2] Southwest Med Univ, Affiliated Tradit Chinese Med Hosp, Dept Gastroenterol, Luzhou 646000, Longmatan, Peoples R China
关键词
Banxia Xiexin decoction; network pharmacology; chronic atrophic gastritis; herb-compoundtarget-disease network; EXPRESSION; CYTOSCAPE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Banxia Xiexin decoction, a traditional herbal mixture, has been widely used for chronic atrophic gastritis in clinical practice in China. However, research on the bioactive components and underlying mechanisms of Banxia Xiexin decoction in chronic atrophic gastritis is still scarce. Components and corresponding targets of Banxia Xiexin decoction were collected from the traditional Chinese medicine systems pharmacology database and analysis platform. The chemical structures of each component were obtained from PubChem. Meanwhile, targets of chronic atrophic gastritis were collected from DrugBank and Online Mendelian Inheritance in Man. Then, the herb-compound-target-disease network and the protein-protein interaction network were constructed based on the data obtained above. Cytoscape network centrality analysis was utilized to filter hub genes and VarElect was used to analyze the relationship between genes and diseases. At last, Metascape was employed for systematic analysis of the potential targets of herbals against chronic atrophic gastritis and AutoDock was applied for molecular docking to verify the results. A total of 214 components were screened as active components and there were 21 shared targets between Banxia Xiexin decoction and chronic atrophic gastritis. Two function modules of Banxia Xiexin decoction were found in the protein-protein interaction network. Further systematic analysis of shared genes and function modules explained the potential mechanism of Banxia Xiexin decoction in the treatment of chronic atrophic gastritis; molecular docking has verified the interactions. Banxia Xiexin decoction could be employed for chronic atrophic gastritis through mechanisms including complex interactions between related components and targets, as predicted by network pharmacology and molecular docking. This work confirmed that Banxia Xiexin decoction could apply for the treatment of chronic atrophic gastritis and promoted the explanation of Banxia Xiexin decoction for chronic atrophic gastritis in the molecular mechanisms.
引用
收藏
页码:291 / 303
页数:13
相关论文
共 50 条
  • [21] BANXIA XIEXIN DECOCTION IMPROVES GASTRIC ATROPHY AND INTESTINAL METAPLASIA IN PATIENTS WITH CHRONIC ATROPHIC GASTRITIS: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED TRIAL
    Yang, Yang
    Fang, Shuangshuang
    Ma, Yanjun
    Liu, Zhaolan
    Zhou, Weixun
    Liu, Xiuli
    Du, Sijing
    Tay, Alfred Chin Yen
    Tang, Yanping
    Zhang, Beiping
    Su, Juanpin
    Wang, Chuijie
    Liu, Fengbin
    Shu, Jin
    Tian, Xudong
    Yang, Qian
    Liu, Huayi
    Liu, Li
    Yu, Tao
    Li, Zhenhua
    Zhang, Zhe
    Wang, Xiaosu
    Xiong, Guangsu
    Song, Gengqing
    Zhang, Ping
    Liu, Jianping
    Wei, Wei
    GASTROENTEROLOGY, 2023, 164 (06) : S519 - S520
  • [22] Network Pharmacology-Based Analysis and Experimental Exploration of Antidiabetic Mechanisms of Gegen Qinlian Decoction
    Xu, Yu
    Huang, Jihan
    Wang, Ning
    Tan, Hor-Yue
    Zhang, Cheng
    Li, Sha
    Tang, Guoyi
    Feng, Yibin
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [23] Network pharmacology based investigation into the effect and mechanism of Modified Sijunzi Decoction against the subtypes of chronic atrophic gastritis
    Tian, Guihua
    Wu, Chuanhong
    Li, Jian
    Liang, Bilin
    Zhang, Feilong
    Fan, Xingxing
    Li, Zewei
    Wang, Yongjun
    Li, Zhihong
    Liu, Di
    Leung, Elaine Lai-Han
    Chen, Jianxin
    PHARMACOLOGICAL RESEARCH, 2019, 144 : 158 - 166
  • [24] Elucidation of the Mechanisms and Molecular Targets of Sanhuang Xiexin Decoction for Type 2 Diabetes Mellitus Based on Network Pharmacology
    Xu, Manman
    Li, Zhonghao
    Yang, Lu
    Zhai, Wujianwen
    Wei, Nina
    Zhang, Qiuyan
    Chao, Bin
    Huang, Shijing
    Cui, Hanming
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [25] Exploring the therapeutic mechanism of Banxia Xiexin Decoction in mild cognitive impairment and diabetes mellitus: a network pharmacology approach
    Cong Li
    Wei Yang
    Yubo Meng
    Lina Feng
    Linlin Sun
    Zhenghong Li
    Xingfang Liu
    Mingquan Li
    Metabolic Brain Disease, 2023, 38 : 2315 - 2325
  • [26] Exploring the therapeutic mechanism of Banxia Xiexin Decoction in mild cognitive impairment and diabetes mellitus: a network pharmacology approach
    Li, Cong
    Yang, Wei
    Meng, Yubo
    Feng, Lina
    Sun, Linlin
    Li, Zhenghong
    Liu, Xingfang
    Li, Mingquan
    METABOLIC BRAIN DISEASE, 2023, 38 (07) : 2315 - 2325
  • [27] Network pharmacology-based elucidation of molecular biological mechanisms of Yiqi Jianpi Decoction for treatment of neuroendocrine neoplasms
    Li, Y.
    Tan, H.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 164 - 164
  • [28] Network pharmacology-based strategy to investigate pharmacological mechanisms of Zuojinwan for treatment of gastritis
    Yu, Guohua
    Wang, Wubin
    Wang, Xu
    Xu, Meng
    Zhang, Lili
    Ding, Lei
    Guo, Rui
    Shi, Yuanyuan
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 18
  • [29] Network pharmacology-based analysis on the key mechanisms of Yiguanjian acting on chronic hepatitis
    Jiang, Xiaodan
    Cui, Xinyi
    Nie, Ruifang
    You, Hongjie
    Tang, Zuoqing
    Liu, Wenlan
    HELIYON, 2024, 10 (09)
  • [30] Network pharmacology-based strategy to investigate pharmacological mechanisms of Zuojinwan for treatment of gastritis
    Guohua Yu
    Wubin Wang
    Xu Wang
    Meng Xu
    Lili Zhang
    Lei Ding
    Rui Guo
    Yuanyuan Shi
    BMC Complementary and Alternative Medicine, 18